Skip to main content
. Author manuscript; available in PMC: 2024 Jan 5.
Published in final edited form as: Int J Pharm. 2022 Nov 24;630:122423. doi: 10.1016/j.ijpharm.2022.122423

Table 4.

Generated trial formulations and their observed responses according to the mixture design.

Code Run Response (%) Code Run Response (%)
Release at 0.5 h Release at 6 h Release at 0.5 h Release at 6 h
F1 1 45.8 100 F11 11 29.6 80.8
F2 2 82.2 90.1 F12 12 35.2 85.0
F3 3 80.1 100 F13 13 19.2 64.5
F4 4 59.4 100 F14 14 69.4 100
F5 5 82.0 100 F15* 15 86.9 100
F6 6 83.1 100 F16 16 82.2 90.1
F7 7 83.1 100 F17 17 72.9 100
F8 8 59.4 100 F18 18 80.1 100
F9 9 49.6 99.9 F19# 19 25.8 63.0
F10 10 81.8 100 F20 20 29.6 80.8
*,#

F15 and F19 are the immediate-release and optimized sustained-release formulations, respectively.